Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSince Eli Lilly raised Mounjaro's UK list prices on 1 September 2025, private costs have shifted noticeably across the board — with the highest-dose pen's list price rising from around £122 to around £330 per four-week pen, according to widely reported figures at the time. If you've searched for the new Mounjaro price and found a confusing range of numbers online, that's not an accident. Private providers set their own prices, prescription fees vary, and the headline figure doesn't always tell the full story. Mounjaro (tirzepatide) is a prescription-only medicine; a prescriber must assess your suitability before any treatment can be issued, which means that any legitimate price you see includes (or should include) a clinical assessment, not just the pen itself.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture the scenario: you search the updated Mounjaro price list, find a number that looks manageable, and click through to order, only to spot a consultation fee added at checkout, or a delivery charge, or a monthly membership just to access the listed rate. This is common enough to be worth spelling out before you compare anything.
Private Mounjaro pricing in the UK typically runs on a dose-by-dose basis. The starter 2.5mg pen sits at the lower end of the range; costs rise with each titration step, and the 15mg maintenance pen sits at the top. Reported private market prices since the September 2025 list-price increase have ranged roughly £149 to £375 per month depending on dose and provider, though these figures move and differ between clinics. What matters more than the headline number is what's bundled inside it.
Common extras that headline prices leave out include the initial consultation fee (sometimes £30 to £80 separately), the prescription fee, delivery, and any ongoing clinical monitoring. Some providers also charge for dose-review appointments or require a subscription to access their lower prices. Discount-based pricing for Mounjaro deserves particular scrutiny, a prescription-only medicine sold via codes or flash offers is a compliance red flag, not a saving.
The full Mounjaro price list context page covers how costs break down across the treatment journey if you want a longer read on what each dose typically costs.
Eli Lilly announced the list-price increase ahead of 1 September 2025. Before that date, UK list prices were substantially lower, which is why some price comparisons circulating online still reference the old figures, and why the same dose might appear at very different costs depending on when a page was last updated.
The change was widely reported. For context, the highest-strength pen moved from a list price of around £122 to around £330, a significant shift that filtered through to private providers at different speeds. Some absorbed part of the increase; others passed it on in full. A provider still advertising 15mg at figures closer to the pre-September 2025 prices warrants a closer look at what's actually being supplied.
For the most current picture of how costs have settled across doses, the Mounjaro price news page tracks what's changed and when. The 5mg updated pricing page looks specifically at one of the most commonly prescribed maintenance doses.
At nume, treatment pricing is shown clearly on the treatment page. A named GPhC-registered prescriber (not an automated system) reads every consultation the same day. That clinical review is part of the price, not an add-on.
This is where it's worth being direct. We are not the cheapest provider. That's a deliberate position, not an oversight.
For a prescription-only medicine like tirzepatide, the right question isn't which provider has the lowest number on their pricing page. It's whether the supply chain is legitimate, whether a qualified prescriber has properly assessed you, and whether you have clinical support if something doesn't feel right after your first pen.
The MHRA has warned publicly about counterfeit weight-loss pens sold through social media and unverified online sellers, in some cases, fake pens have been found to contain insulin rather than tirzepatide. In 2025, approximately 20 million doses of illegally traded weight-loss medicines were seized, with a street value of around £45 million. The common thread: prices that undercut the legitimate market significantly, often promoted with discount codes or without any visible clinical process. You can verify any UK online pharmacy on the GPhC register, a step that takes about thirty seconds and tells you quickly whether a pharmacy is regulated.
A small saving on one pen is not worth the risk of an unverified supply. That's not a scare tactic; it's what the MHRA's own guidance makes clear.
At nume) at nume, one transparent price covers everything listed in the section above: consultation, prescription, medicine, and tracked delivery to your door. The new Mounjaro prices page has a full breakdown of current costs across each dose. If you want to understand the broader treatment before looking at pricing, the weight-loss treatment overview is a good place to start, and the Mounjaro pillar page covers the clinical picture in full.
Our prescribers (you can read more about our clinical team here) review every consultation personally. Questions about your specific situation go to our support team, who are available seven days a week.
If you're ready to find out whether Mounjaro is clinically appropriate for you, the free consultation is the right next step.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.